DE60323743D1 - N-(substituierte benzyl)-8-hydroxy-1,6-naphthyridin-7- carbonsäureamide als hiv-integrase-hemmer - Google Patents
N-(substituierte benzyl)-8-hydroxy-1,6-naphthyridin-7- carbonsäureamide als hiv-integrase-hemmerInfo
- Publication number
- DE60323743D1 DE60323743D1 DE60323743T DE60323743T DE60323743D1 DE 60323743 D1 DE60323743 D1 DE 60323743D1 DE 60323743 T DE60323743 T DE 60323743T DE 60323743 T DE60323743 T DE 60323743T DE 60323743 D1 DE60323743 D1 DE 60323743D1
- Authority
- DE
- Germany
- Prior art keywords
- hiv
- sup
- hydroxy
- compounds
- integrase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36492902P | 2002-03-15 | 2002-03-15 | |
PCT/US2003/007448 WO2003077850A2 (en) | 2002-03-15 | 2003-03-12 | N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60323743D1 true DE60323743D1 (en) | 2008-11-06 |
Family
ID=28041987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60323743T Expired - Lifetime DE60323743D1 (en) | 2002-03-15 | 2003-03-12 | N-(substituierte benzyl)-8-hydroxy-1,6-naphthyridin-7- carbonsäureamide als hiv-integrase-hemmer |
Country Status (8)
Country | Link |
---|---|
US (1) | US7323460B2 (de) |
EP (1) | EP1496836B1 (de) |
JP (1) | JP4494020B2 (de) |
AT (1) | ATE409187T1 (de) |
AU (2) | AU2003220170B2 (de) |
CA (1) | CA2478310A1 (de) |
DE (1) | DE60323743D1 (de) |
WO (2) | WO2003077857A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4494020B2 (ja) * | 2002-03-15 | 2010-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | Hivインテグラーゼ阻害剤として有用なn−(置換ベンジル)−8−ヒドロキシ−1,6−ナフチリジン−7−カルボキサミド |
US7358249B2 (en) | 2002-08-13 | 2008-04-15 | Shionogi & Co., Ltd. | Heterocyclic compounds having inhibitory activity against HIV integrase |
PA8586801A1 (es) | 2002-10-31 | 2005-02-04 | Pfizer | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso |
CA2513141A1 (en) | 2003-01-27 | 2004-08-12 | Pfizer Inc. | Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
US20060211687A1 (en) * | 2003-03-12 | 2006-09-21 | Michael Palucki | Potassium salt of an hiv integrase inhibitor |
AU2004274493A1 (en) * | 2003-09-19 | 2005-03-31 | Gilead Sciences, Inc. | Aza-quinolinol phosphonate integrase inhibitor compounds |
WO2005041664A1 (en) | 2003-10-20 | 2005-05-12 | Merck & Co., Inc. | Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors |
JP4789144B2 (ja) * | 2004-02-04 | 2011-10-12 | 塩野義製薬株式会社 | Hivインテグラーゼ阻害活性を有するナフチリジン誘導体 |
WO2005087768A1 (en) * | 2004-03-09 | 2005-09-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
WO2005103003A2 (en) * | 2004-04-26 | 2005-11-03 | Pfizer Inc. | Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors |
BRPI0510306A (pt) | 2004-04-26 | 2007-09-04 | Pfizer | inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso |
EP1942736A2 (de) * | 2005-10-27 | 2008-07-16 | Merck & Co., Inc. | Hiv-integrasehemmer |
KR101081149B1 (ko) | 2006-09-07 | 2011-11-07 | 에미스페어 테크놀로지스, 인코포레이티드 | Snac(살카프로제이트 나트륨)의 제조 방법 |
CN106117196A (zh) * | 2016-06-09 | 2016-11-16 | 青岛辰达生物科技有限公司 | 一种制备抗癌药物达沙替尼的方法 |
CN107722106A (zh) * | 2016-08-11 | 2018-02-23 | 重庆大学 | Hiv抑制剂 |
CN112409267A (zh) * | 2019-08-22 | 2021-02-26 | 江苏阿尔法药业有限公司 | 一种索菲布韦中间体的制备方法 |
AR122928A1 (es) * | 2020-07-10 | 2022-10-19 | Goldfinch Bio Inc | 1,6-naftiridinas sustituidas inhibidoras de cdk5 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5751837B2 (de) | 1973-04-05 | 1982-11-04 | ||
US4416884A (en) | 1978-04-12 | 1983-11-22 | Otsuka Pharmaceutical Co., Ltd. | Piperazinylbenzoheterocyclic compounds |
FR2632639B1 (fr) | 1988-06-09 | 1990-10-05 | Sanofi Sa | Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent |
IL101860A0 (en) | 1991-05-31 | 1992-12-30 | Ici Plc | Heterocyclic derivatives |
TW263498B (de) | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
US5776944A (en) | 1994-06-16 | 1998-07-07 | Lg Chemical Ltd. | 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof |
EP0688772B1 (de) | 1994-06-16 | 1999-05-06 | LG Chemical Limited | Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung |
US5681832A (en) | 1995-02-17 | 1997-10-28 | The United States Of America As Represented By The Department Of Health And Human Services | Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity |
DE69631423T2 (de) | 1995-08-02 | 2004-12-02 | Darwin Discovery Ltd., Slough | Chinolone und deren therapeutische verwendung |
US5945431A (en) | 1996-03-15 | 1999-08-31 | Biochem Therapeutics Incorporated | Cytomegalovirus inhibiting compounds |
JP2002505660A (ja) | 1996-09-10 | 2002-02-19 | ファルマシア・アンド・アップジョン・カンパニー | 抗ウィルス剤としての8―ヒドロキシ―7―置換キノリン |
EP0929526B1 (de) | 1996-09-25 | 2005-07-27 | AstraZeneca AB | Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern |
ATE285410T1 (de) | 1997-06-30 | 2005-01-15 | Nippon Kayaku Kk | Naphthyridinderivate oder salze davon |
IL134291A0 (en) | 1997-08-25 | 2001-04-30 | Neurogen Corp | Substituted 4-oxo-napthyridine-3- carboxamides as gaba brain receptor ligands |
GB9720052D0 (en) | 1997-09-19 | 1997-11-19 | Smithkline Beecham Plc | Novel compounds |
JP4256065B2 (ja) | 1997-09-30 | 2009-04-22 | 第一三共株式会社 | スルホニル誘導体 |
JP2001525365A (ja) * | 1997-12-11 | 2001-12-11 | バイオケム・フアーマ・インコーポレーテツド | 抗ウイルス化合物 |
DE69831506T2 (de) | 1997-12-22 | 2006-06-29 | Pharmacia & Upjohn Co. Llc, Kalamazoo | 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe |
EP1083897A4 (de) | 1998-06-03 | 2003-01-02 | Merck & Co Inc | Hiv integrase-inhibitoren |
US6380249B1 (en) | 1998-06-03 | 2002-04-30 | Merck & Co., Inc. | HIV integrase inhibitors |
US6306891B1 (en) | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
CA2333771A1 (en) | 1998-06-03 | 1999-12-09 | Mark W. Embrey | Hiv integrase inhibitors |
US6262055B1 (en) | 1998-06-03 | 2001-07-17 | Merck & Co., Inc. | HIV integrase inhibitors |
EP1082121A4 (de) | 1998-06-03 | 2003-02-05 | Merck & Co Inc | Hiv-integraseinhibitoren |
SE9802550D0 (sv) | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
IL140868A0 (en) * | 1998-08-11 | 2002-02-10 | Pfizer Prod Inc | Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
CA2370500A1 (en) | 1999-06-25 | 2001-01-04 | Lekhanh O. Tran | 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
EP1297834A4 (de) | 2000-06-14 | 2007-05-09 | Shionogi & Co | Enzyminhibitor mit zwei divalenten metallionen als aktiven zentren |
US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
GB0017676D0 (en) | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
WO2002009504A1 (en) * | 2000-08-02 | 2002-02-07 | George Robert A | Squirrel-proof bird feeding apparatus and method |
SK4322003A3 (en) * | 2000-10-12 | 2003-09-11 | Merck & Co Inc | Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
US20050010048A1 (en) | 2000-10-12 | 2005-01-13 | Linghang Zhuang | Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
AU1532802A (en) | 2000-10-12 | 2002-04-22 | Merck & Co Inc | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
ATE345129T1 (de) | 2000-10-12 | 2006-12-15 | Merck & Co Inc | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer |
PL365027A1 (en) | 2001-03-01 | 2004-12-27 | Shionogi & Co, Ltd. | Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
AR036256A1 (es) | 2001-08-17 | 2004-08-25 | Merck & Co Inc | Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento |
CA2463975A1 (en) | 2001-10-26 | 2003-05-01 | Maria Emilia Di Francesco | Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
EA007060B1 (ru) | 2001-10-26 | 2006-06-30 | Иституто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа | N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы |
JP4494020B2 (ja) * | 2002-03-15 | 2010-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | Hivインテグラーゼ阻害剤として有用なn−(置換ベンジル)−8−ヒドロキシ−1,6−ナフチリジン−7−カルボキサミド |
EP1499391A2 (de) | 2002-04-10 | 2005-01-26 | Merck & Co., Inc. | Pharmazeutische zusammensetzungen mit einem hiv-integrase-hemmer und einem nichtionischen tensid |
-
2003
- 2003-03-12 JP JP2003575904A patent/JP4494020B2/ja not_active Expired - Fee Related
- 2003-03-12 DE DE60323743T patent/DE60323743D1/de not_active Expired - Lifetime
- 2003-03-12 CA CA002478310A patent/CA2478310A1/en not_active Abandoned
- 2003-03-12 EP EP03716466A patent/EP1496836B1/de not_active Expired - Lifetime
- 2003-03-12 AU AU2003220170A patent/AU2003220170B2/en not_active Ceased
- 2003-03-12 US US10/508,094 patent/US7323460B2/en not_active Expired - Fee Related
- 2003-03-12 WO PCT/US2003/007671 patent/WO2003077857A2/en not_active Application Discontinuation
- 2003-03-12 WO PCT/US2003/007448 patent/WO2003077850A2/en active Search and Examination
- 2003-03-12 AU AU2003218130A patent/AU2003218130A1/en not_active Abandoned
- 2003-03-12 AT AT03716466T patent/ATE409187T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2003220170B2 (en) | 2008-12-11 |
JP2005527521A (ja) | 2005-09-15 |
AU2003218130A1 (en) | 2003-09-29 |
AU2003220170A1 (en) | 2003-09-29 |
WO2003077857A2 (en) | 2003-09-25 |
US20050176955A1 (en) | 2005-08-11 |
EP1496836B1 (de) | 2008-09-24 |
AU2003218130A8 (en) | 2003-09-29 |
EP1496836A4 (de) | 2006-03-22 |
ATE409187T1 (de) | 2008-10-15 |
WO2003077850A2 (en) | 2003-09-25 |
CA2478310A1 (en) | 2003-09-25 |
EP1496836A2 (de) | 2005-01-19 |
WO2003077850A3 (en) | 2004-11-11 |
WO2003077857A3 (en) | 2006-06-08 |
JP4494020B2 (ja) | 2010-06-30 |
US7323460B2 (en) | 2008-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2020026I1 (no) | Raltegravir eller et farmasøytisk akseptabelt salt derav, spesielt kaliumsaltet | |
EP1467970A4 (de) | Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen | |
ATE364385T1 (de) | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer | |
ATE345129T1 (de) | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer | |
YU27903A (sh) | Aza- i poliaza-naftalenil karboksamidi korisni kao inhibitori hiv-integraze | |
SI1441734T1 (sl) | Dihidropirimidin karboksamidni inhibitorji HIV-integraze | |
DE60323743D1 (en) | N-(substituierte benzyl)-8-hydroxy-1,6-naphthyridin-7- carbonsäureamide als hiv-integrase-hemmer | |
EP1539714A4 (de) | 8-hydroxy-1-oxotetrahydropyrrolopyrazinverbindungen, die sich als inhibitoren von hiv-integrase eignen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: MERCK SHARP & DOHME CORP., NEW JERSEY, N.J., US |